Analgesic Effect of Intrathecal Ginsenosides in a Murine Bone Cancer Pain
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background:Bone cancer pain has a disruptive effect on the cancer patient’s quality of life. Although ginsenosides have been used as traditional medicine in Eastern Medicine, the effect on bone cancer pain has not been thoroughly studied. The aim of this study was to determine whether ginsenosides may alter the bone cancer pain at the spinal level. Methods:NCTC 2472 tumor cells (2.5 × 105) were injected into the femur of adult male C3H/HeJ mice to evoke bone tumor and bone cancer pain. To develop bone tumor, radiologic pictures were obtained. To assess pain, the withdrawal threshold was measured by applying a von Frey filament to the tumor cells inoculation site. The effect of intrathecal ginsenosides was investigated. Effect of ginsenosides (150, 500, 1,000 mg) was examined at 15, 30, 60, 90, 120 min after intrathecal delivery. Results:The intrafemoral injection of NCTC 2472 tumor cells induced a radiological bone tumor. The withdrawal threshold with tumor development was significantly decreased compared to the sham animals. Intrathecal ginsenosides effectively increased the withdrawal threshold in the bone cancer site. Conclusions:NCTC 2472 tumor cells injection into the mice femur caused bone tumor and bone cancer pain. Intrathecal ginsenosides attenuated the bone cancer-related pain behavior. Therefore, spinal ginsenosides may be an alternative analgesic for treating bone cancer pain. (Korean J Pain 2010; 23: 230-235)
Abstract
Background:Bone cancer pain has a disruptive effect on the cancer patient’s quality of life. Although ginsenosides have been used as traditional medicine in Eastern Medicine, the effect on bone cancer pain has not been thoroughly studied. The aim of this study was to determine whether ginsenosides may alter the bone cancer pain at the spinal level. Methods:NCTC 2472 tumor cells (2.5 × 105) were injected into the femur of adult male C3H/HeJ mice to evoke bone tumor and bone cancer pain. To develop bone tumor, radiologic pictures were obtained. To assess pain, the withdrawal threshold was measured by applying a von Frey filament to the tumor cells inoculation site. The effect of intrathecal ginsenosides was investigated. Effect of ginsenosides (150, 500, 1,000 mg) was examined at 15, 30, 60, 90, 120 min after intrathecal delivery. Results:The intrafemoral injection of NCTC 2472 tumor cells induced a radiological bone tumor. The withdrawal threshold with tumor development was significantly decreased compared to the sham animals. Intrathecal ginsenosides effectively increased the withdrawal threshold in the bone cancer site. Conclusions:NCTC 2472 tumor cells injection into the mice femur caused bone tumor and bone cancer pain. Intrathecal ginsenosides attenuated the bone cancer-related pain behavior. Therefore, spinal ginsenosides may be an alternative analgesic for treating bone cancer pain. (Korean J Pain 2010; 23: 230-235)
참고문헌 (26)
- Portenoy RK, "Management of cancer pain", Lancet, 353, pp.1695~1700 (1999)
- Banning A, "Pain causes in 200 patients referred to a multidisciplinary cancer pain clinic", Pain, 45, pp.45~48 (1991)
- Coleman RE, "A randomised phase II study of oral pamidronate for the treatment of bone metastases from breast cancer", Eur J Cancer, 34, pp.820~824 (1998)
- Coleman RE, "How can we improve the treatment of bone metastases further?", Curr Opin Oncol, 10(Suppl 1), pp.7~13 (1998)
- Mercadante S, "Breakthrough pain in cancer patients: pathophysiology and treatment", Cancer Treat Rev, 24, pp.425~432 (1998)
- Mercadante S, "Malignant bone pain: pathophysiology and treatment", Pain, 69, pp.1~18 (1997)
- Portenoy RK, "Breakthrough pain: characteristics and impact in patients with cancer pain", Pain, 81, pp.129~134 (1999)
- Mercadante S, "Management of painful bone metastases", Curr Opin Oncol, 19, pp.308~314 (2007)
- O'Connor JP, "Celecoxib, NSAIDs and the skeleton", Drugs Today (Barc), 44, pp.693~709 (2008)
- Vanderah TW, "Dynorphin promotes abnormal pain and spinal opioid antinociceptive tolerance", J Neurosci, 20, pp.7074~7079 (2000)
- Liu CX, "Recent advances on ginseng research in China", J Ethnopharmacol, 36, pp.27~38 (1992)
- Attele AS, "Ginseng pharmacology: multiple constituents and multiple actions", Biochem Pharmacol, 58, pp.1685~1693 (1999)
- Nah JJ, "Effect of ginsenosides, active components of ginseng, on capsaicin- induced pain-related behavior", Neuropharmacology, 39, pp.2180~2184 (2000)
- 신동진, "백서를 이용한 수술 후 통증 유발 모형에서 척수강 내로 투여한 Ginsenosides의 효과", The Korean Journal of Pain, 20(2), pp.3~3 (2007), 대한통증학회
- 김세열, "쥐의 척수강 내로 투여한 고려 홍삼의 항통각효과에 대한 아드레날린성 및 콜린성 수용체 역할", The Korean Journal of Pain, 21(1), pp.27~32 (2008), 대한통증학회
- Schwei MJ, "Neurochemical and cellular reorganization of the spinal cord in a murine model of bone cancer pain", J Neurosci, 19, pp.10886~10897 (1999)
- Hylden JL, "Intrathecal morphine in mice: a new technique", Eur J Pharmacol, 67, pp.313~316 (1980)
- Dixon WJ, "Efficient analysis of experimental observations", Annu Rev Pharmacol Toxicol, 20, pp.441~462 (1980)
- Yoon MH, "Antinociception of intrathecal cholinesterase inhibitors and cholinergic receptors in rats", Acta Anaesthesiol Scand, 47, pp.1079~1084 (2003)
- Nah SY, "Ginseng; recent advances and trends", Korean J Ginseng Sci, 21, pp.1~12 (1997)
- Kaku T, "Chemico- pharmacological studies on saponins of Panax ginseng C. A. Meyer. II. Pharmacological part", Arzneimittelforschung, 25, pp.539~547 (1975)
- Lee JH, "Differential effect of bovine serum albumin on ginsenoside metabolite-induced inhibition of alpha3beta4 nicotinic acetylcholine receptor expressed in Xenopus oocytes", Arch Pharm Res, 26, pp.868~873 (2003)
- Nah SY, "Ginseng root extract inhibits calcium channels in rat sensory neurons through a similar path, but different receptor, as mu-type opioids", J Ethnopharmacol, 42, pp.45~51 (1994)
- Nah SY, "A trace component of ginseng that inhibits Ca2+ channels through a pertussis toxin-sensitive G protein", Proc Natl Acad Sci USA, 92, pp.8739~8743 (1995)
- Rhim H, "Ginseng and ginsenoside Rg3, a newly identified active ingredient of ginseng, modulate Ca2+ channel currents in rat sensory neurons", Eur J Pharmacol, 436, pp.151~158 (2002)
- Shin YH, "Ginsenosides that produce differential antinociception in mice", Gen Pharmacol, 32, pp.653~659 (1999)
